Jan Kramer
Overview
Explore the profile of Jan Kramer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waldeck F, Kramer T, Boutin S, Matten J, Kramer J, Rupp J
BMC Infect Dis
. 2025 Mar;
25(1):318.
PMID: 40050786
Background: Mycoplasma pneumoniae (M. pneumoniae) is a common pathogen of community-acquired pneumonia (CAP). Epidemics occur every 3-7 years especially in pediatric patients. We collected data from a large laboratory network...
2.
Reuter T, Muller M, Stelter F, Durner J, Kramer J
PLoS One
. 2024 Dec;
19(12):e0313572.
PMID: 39652602
Objectives: In most countries the majority of patients are in outpatient care. In difference to hospitalized patients, their blood samples often take hours after collection to centrifugation. The study investigates...
3.
Herta T, Joachim-Richter A, Petroff D, Wolk B, Wolffram I, Berg T, et al.
Aliment Pharmacol Ther
. 2024 Dec;
61(4):651-657.
PMID: 39628411
Background: Despite European guidelines recommending anti-hepatitis D virus (HDV) screening for all hepatitis B surface antigen (HBsAg)-positive cases, screening rates remain insufficient. Aims: We analysed anti-HDV screening rates in primary...
4.
Batz O, Petroff D, Jedrysiak K, Wolffram I, Berg T, Kramer J, et al.
JHEP Rep
. 2024 Aug;
6(9):101122.
PMID: 39188540
Background & Aims: A goal of the World Health Organization's global hepatitis strategy is the elimination of chronic hepatitis C virus (HCV) infection by 2030. As part of its strategy,...
5.
Kading N, Waldeck F, Meier B, Boutin S, Borsche M, Balck A, et al.
Front Public Health
. 2024 Jul;
12:1415778.
PMID: 38979040
Trial Registration: DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418, Registered on 28 October 2020.
6.
Hubens W, Maie T, Schnitker M, Bocova L, Puri D, Wessiepe M, et al.
Clin Chem
. 2023 Sep;
69(11):1283-1294.
PMID: 37708296
Background: Cell-type specific DNA methylation (DNAm) can be employed to determine the numbers of leukocyte subsets in blood. In contrast to conventional methods for leukocyte counts, which are based on...
7.
Steinborn C, Tancredi A, Habiger C, Diederich C, Kramer J, Reingruber A, et al.
Chemistry
. 2023 Feb;
29(39):e202300199.
PMID: 36807428
We report the design, synthesis and biological evaluation of simplified analogues of the herbicidal natural product (+)-cornexistin. Guided by an X-Ray co-crystal structure of cornexistin bound to transketolase from Zea...
8.
Teufel A, Geier A, Sarrazin C, Schattenberg J, Kautz A, Dorner R, et al.
Z Gastroenterol
. 2023 Feb;
61(8):1028-1036.
PMID: 36791784
The prevalence of fatty liver disease has increased significantly in Germany in recent years. With an estimated 18 million German citizens being affected, it is now among the most prevalent...
9.
Zablowsky N, Farack L, Rofall S, Kramer J, Meyer H, Nguyen D, et al.
Noncoding RNA
. 2023 Jan;
9(1).
PMID: 36649031
Traditionally, small molecule-based drug discovery has mainly focused on proteins as the drug target. Opening RNA as an additional target space for small molecules offers the possibility to therapeutically modulate...
10.
Petroff D, Wolffram I, Batz O, Jedrysiak K, Kramer J, Berg T, et al.
Liver Int
. 2023 Jan;
43(4):785-793.
PMID: 36621849
Background And Aims: Screening strategies for undiagnosed infections are fundamental for hepatitis C virus (HCV) elimination. We previously investigated HCV prevalence and screening strategies in an urban primary care setting....